MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours

Impact of MYC in regulation of tumor cell metabolism

(2015) Therese Wahlström et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer

(2015) Erik S Knudsen et al.   CELL CYCLE

Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells

(2015) Zhike Chen et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP

(2015) Liangliang Shen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay

(2014) Fabrício F. T. Barros et al.   BREAST CANCER RESEARCH AND TREATMENT

MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer

(2014) Ayesha N Shajahan-Haq et al.   Molecular Cancer

DNA polymerase β deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts

(2014) Tarek M.A. Abdel-Fatah et al.   Molecular Oncology

The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer

(2013) Hany Onsy Habashy et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer

(2013) B. Li et al.   CLINICAL CANCER RESEARCH

c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer

(2013) R Nair et al.   ONCOGENE

MYC on the Path to Cancer

(2012) Chi V. Dang   CELL

Anticancer Activity and Cellular Repression of c-MYC by the G-Quadruplex-Stabilizing 11-Piperazinylquindoline Is Not Dependent on Direct Targeting of the G-Quadruplex in the c-MYC Promoter

(2012) Peda V. L. Boddupally et al.   JOURNAL OF MEDICINAL CHEMISTRY

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

PiNGO: a Cytoscape plugin to find candidate genes in biological networks

(2011) M. Smoot et al.   BIOINFORMATICS

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

(2011) Pascal Jézéquel et al.   BREAST CANCER RESEARCH AND TREATMENT

18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers

(2011) N. Palaskas et al.   CANCER RESEARCH

Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms

(2011) Pixu Liu et al.   NATURE MEDICINE

Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer

(2010) Mohammed A. Aleskandarany et al.   BREAST CANCER RESEARCH AND TREATMENT

Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage

(2010) Lina Guerra et al.   PLoS One

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis

(2009) Mohammed A. Aleskandarany et al.   BREAST CANCER RESEARCH AND TREATMENT

A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks

(2009) L. J. Lancashire et al.   BREAST CANCER RESEARCH AND TREATMENT

The Role of Myc-Induced Protein Synthesis in Cancer

(2009) D. Ruggero   CANCER RESEARCH

Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer

(2009) R. Agarwal et al.   CLINICAL CANCER RESEARCH

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

(2009) E. A. Rakha et al.   CLINICAL CANCER RESEARCH

Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors

(2008) Shiro Miura et al.   CANCER

Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer

(2008) Elizabeth A. Musgrove et al.   PLoS One